NIH-funded research R01 grant

A device for tracking radiation doses to organs during treatment.

Official title: The Personalized Remote Radiation Tracking Portable Organ Dosimetry Devise (PRRT PODD)

Funded at University of Washington · NIH-10988083 · Data updated 2026-11-12

This study is testing a handy device that helps keep track of how much radiation your organs receive during treatment for neuroendocrine tumors, so your doctors can create a more personalized plan that works best for you while reducing side effects.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 9, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$596,095
NIH project number1R01CA287205-01A1
Project IDNIH-10988083 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with neuroendocrine tumors who are undergoing treatment with 177Lu-DOTATATE.

Less likely to help

Patients who do not have neuroendocrine tumors or are not receiving targeted radiation therapy may not benefit from this research.

What this research studies

This research focuses on developing a portable device that tracks radiation doses to organs during targeted therapies for neuroendocrine tumors. By using advanced imaging techniques, the device aims to personalize treatment plans based on individual organ dosimetry, potentially improving patient outcomes. The approach involves quantifying radiation exposure to organs at risk and tumors, allowing for tailored therapy that maximizes effectiveness while minimizing side effects. Patients will be monitored throughout their treatment to ensure optimal dosing.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective radiation treatments for patients with neuroendocrine tumors.

How similar studies have gone: Previous studies have shown promising results in personalizing radiation therapy, indicating that this approach could be effective.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Miyaoka, Robert S — University of Washington
  • Study coordinator: Miyaoka, Robert S

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.